Medical Device News Magazine

EB-Plate Is the First Completely Reusable 3D Cell Culture Microplate Launched by eNUVIO

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 8, 2020

EB-Plate, is the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use plastics – from serological pipettes and pipette tips to vials and culture microplates – these are just a few of the many plastic items thrown in the garbage in labs every day.

eNUVIO’s completely reusable EB-Plate comes to the market at the right time as the demand for 3D cell culture microplates is high, conventional plastic plates are currently in short supply, and the zero-waste movement is becoming increasingly popular in laboratories. As with many emerging environmentally friendly options, it’s no surprise that the reusable and virtually indestructible EB-Plate comes in at a higher cost compared to its plastic counterparts. According to the company, the new plates pay for themselves after approximately 5-8 uses, and can be reused many times more.

eNUVIO* understands the hesitation to switch from tried-and-true devices to new tools, but asserts that in the case of the EB-Plate, scientists don’t have to compromise quality when switching from conventional single-use microplates to a greener choice. This new plate allows researchers to generate embryoid bodies, the necessary first step to growing larger self-assembled 3D cultures known as spheroids or organoids from stem cells. Owing to the unique geometry of each microwell, uniformly-sized spheroids can be generated with high reproducibility, and the high-transmissive plate bottom enables high-quality optical observation. The company anticipates that researchers will benefit from this environmentally-friendly device for a long time, both scientifically and economically.

3D cell cultures are quickly emerging as the next generation tools of choice for safety pharmacology and drug screening purposes. As such, conventional single-use plastic 3D cell culture microplates are increasingly being used in CROs, biotech and pharmaceutical companies as well as for fundamental research in academic and government laboratories. eNUVIO opens the door to researchers around the world to access the first, completely reusable and environmentally-friendly 3D cell culture microplate on the market. The company is banking on labs embracing greener choices in their workflows, and is working to expand their environmentally-friendly product offerings.

EB-PLATE Specifications:

  • 96 microwells/plate
  • Microplate outer dimensions: 127.7 x 85.4 mm
  • Chamber material: Polydimethylsiloxane (PDMS), biologically inert, non-degradable
  • Microplate height (w/o lid): 14.2 mm
  • Microwell opening diameter: 6 mm
  • Microwell diameter at base: 900 µm
  • Microplate bottom thickness: 1 mm
  • Chamber volume: 250 µl
  • Chamber pitch: 9 mm
  • Shipped sterile, ultra-low attachment (ULA) surface
  • In-house production ensures high quality at all times
  • Sold directly through enuvio.com or via scienceexchange.com


“The first step in a new direction is always hard to take, and the EB-Plate finally gives research labs the ability to make a green choice when it comes to embryoid and spheroid generation. There are basically no other green options on the market”, says Mark Aurousseau, CSO and co-founder of eNUVIO, Montreal, Canada.
He continues: “I’ve spoken to many scientists that sometimes just want to use a couple of wells of a plate for an experiment since reagents for this type of research can be quite expensive. They find themselves feeling horrible when they have no option but to throw out a half unused plate.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”